google-site-verification: googlec7193c3de77668c9.html

Trial finds immunotherapy did not improve survival when added to chemoradiotherapy for small cell lung cancer

[
Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international clinical trial, NRG-LU005, led by NRG Oncology in collaboration with the Alliance for Clinical Trials in Oncology. The results are published in the Journal of Clinical Oncology.


Source link

Advertisements

See also  Researchers create choir of children born with heart condition

Check Also

Study tracks early adoption of liver histotripsy treatment

[ It has been nearly three years since the U.S. Food and Drug Administration (FDA) …

Even symptom-free IBD patients show gut cells primed for damage, study finds

[ Image taken through spatial transcriptomics showing patterns of cell death-related genes in gut tissue …

Ctscan.jpg

No benefit of heart CT scan in patients with acute chest pain, trial finds

[ Credit: Pixabay/CC0 Public Domain Coronary CT angiography (CTCA) scans do not reduce the risk …

Leave a Reply

Available for Amazon Prime